Skip to content

Questex’s Fierce JPM Week 2021 gathers top biopharma and healthcare leaders to explore the latest issues, from COVID-19 to the post-pandemic future

NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — Questex’s Fierce JPM Week 2021, the premier event for leading experts and executives in the biopharma and healthcare industry, is scheduled to take place January 11–13, 2021. The three-day virtual event will deliver CEO interviews, panel discussions and company presentations exploring biopharma’s ongoing work to combat COVID-19 and the world’s other diseases. Register here.

“Normally in January, the biopharma world would descend on San Francisco for the J.P. Morgan Healthcare Conference. But as we all know, that world is a long way away and virtual is our new reality,” says Rebecca Willumson, Vice President & Publisher, Fierce Pharma. “We created Fierce JPM Week to continue our industry coverage through a virtual event that will bring you a more in depth perspective from the leaders of the biopharma world.”

Fierce JPM Week will feature interviews and presentations from the following thought leaders:

  • Samit Hirawat, M.D., Chief Medical Officer, Bristol Myers Squibb
  • Stéphane Bancel, CEO, Moderna
  • Levi Garraway, M.D., Ph.D., Chief Medical Officer, Roche and Genentech 
  • Rick Gates, Senior Vice President – Pharmacy and Healthcare, Walgreens
  • Ruud Dobber, EVP and President, BioPharmaceuticals Business Unit, AstraZeneca 
  • David Feinberg, M.D., Vice President, Google Health
  • Mariola Fotin-Mleczek, Ph.D., Chief Technology Officer, CureVac
  • Alexander Hardy, CEO, Genentech 
  • Daphne Koller, CEO and Founder, insitro 
  • Ann Leen, Ph.D., Chief Scientific Officer, AlloVir 
  • Heather Zenk, SVP of Strategic Global Sourcing, AmerisourceBergen 
  • Halee Fischer-Wright, M.D., President and CEO, Medical Group Management Association (MGMA) 

The event will offer several panel discussions including:

  • In-development COVID-19 therapeutics 
  • “Second-wave” COVID-19 vaccines 
  • The last mile: How will a COVID-19 vaccine make it from plant to patients? 

A special thanks to our sponsors: Bayer, Catalent Biologics, Clarivate Analytics, Elligo Health Research, FUJIFILM Diosynth Biotechnologies, Google Chrome Enterprise, Honeywell, Komodo Health, Lore IO, Medable, Molecular Health GmbH, PhRMA, RxE2, Takeda, TD2, Thermo Fisher and Wacker Biotech GmbH.

Learn more about Fierce JPM Week here. To register to attend Fierce JPM Week, click here. The event is free for biopharma and healthcare organizations.

For sponsorship opportunities, contact Angelique Alcover at aalcover@questex.com.

Stay connected with Fierce JPM Week on LinkedIn and Twitter.

About Questex
Questex helps people live better and longer. Questex brings people together in the markets that help people live better: travel, hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.

Media Contact
Emily Schriver
Marketing Manager
Questex
eschriver@questex.com

 

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn